Category NASDAQ
Major U.S. Stock Market Performance — Major Indices — Between Memorial Day To Labor Day; 2018 Hurricane Season Could Whip Up Commodities; Nektar Pharmaceuticals Surges/Bio-Tech Breakout
Major U.S. Stock Market Performance — Major Indices — Between Memorial Day To Labor Day; 2018 Hurricane Season Could Whip Up Commodities; Nektar Pharmaceuticals Surges/Bio-Tech Breakout http://www.fortunascorner.com Kensho Analytics, provided a chart to CNBC’s Half Time hosts on Friday, regarding the historical performance of the major U.S. stock indices since 1990 — if you […]
Despite Recent Price Drop, Bitcoin Gets Vote Of Confidence; How To Play China Now
Despite Recent Price Drop, Bitcoin Gets Vote Of Confidence; How To Play China Now http://www.fortunascorner.com Avi Salzman had a full-page article in this weekend’s (May 21, 2018) Barron’s, “Despite Recent Price Drop, Bitcoin Gets Vote Of Confidence.” “Bitcoin has plunged 58 percent from its December highs, Warren Buffet has compared it to rat poison, and […]
‘Why Stocks Can’t Wait For The Midterms To Be Over’; After Iran Decision, Top Oil Analyst Is Bullish On The Commodity Short-Term, Says We Could See A “Dramatic Rise,” If We Get Tropical Storms This Summer
‘Why Stocks Can’t Wait For The Midterms To Be Over’; After Iran Decision, Top Oil Analyst Is Bullish On The Commodity Short-Term, Says We Could See A “Dramatic Rise,” If We Get Tropical Storms This Summer http://www.fortunascorner.com The title above is from Mark Hulbert’s May 7, 2018 article in the Wall Street Journal. Mr. […]
“The Bottom Is In,” For Stocks; Worst Behind Us, According To One Of Wall Street’s Top Forecasters; Expects S&P 500 To End The Year Around 3,000 — Or About +13 Percent From Friday’s Close; Saturday Deadline Looms On 2015 Iran Nuclear Deal
“The Bottom Is In,” For Stocks; Worst Behind Us, According To One Of Wall Street’s Top Forecasters; Expects S&P 500 To End The Year Around 3,000 — Or About +13 Percent From Friday’s Close; Saturday Deadline Looms On 2015 Iran Nuclear Deal http://www.fortunascorner.com Marco Kolanovic, Global Head of Derivatives and Quntitative Strategy […]
‘Sell In May & Go Away?” That Strategy Has Worked Only Once In The Past Six Years; Healthcare Is The Best Sector To Be Invested In May-October Since 1990, Averaging A 6.29 Percent Gain, While S&P Index Averaged A 1.83 Percent Loss
‘Sell In May & Go Away?” That Strategy Has Worked Only Once In The Past Six Years; Healthcare Is The Best Sector To Be Invested In May-October Since 1990, Averaging A 6.29 Percent Gain, While S&P Index Averaged A 1.83 Percent Loss http://www.fortunascorner.com ‘Sell In May And Go Away,’ is one of […]
Futures Were Pointing To Another Selloff On Wall Street Early This Morning; But, Are Now Flat To Positive As We Near The Opening Bell; ‘Don’t Get Hung Up On 3 Percent 10-Year Yields’
Futures Were Pointing To Another Selloff On Wall Street Early This Morning; But, Are Now Flat To Positive As We Near The Opening Bell; ‘Don’t Get Hung Up On 3 Percent 10-Year Yields’ https://fortunascorner.com Stock futures this morning were initially pointing to another selloff on Wall Street; but, as the morning as […]
Stock Market To Focus On Earnings This Week With One-Third Of The S&P 500 Set To Announce Q1/2018 Earnings & Forecasts; ‘The Looming Battle Over Artificial Intelligence Chips
Stock Market To Focus On Earnings This Week With One-Third Of The S&P 500 Set To Announce Q1/2018 Earnings & Forecasts; ‘The Looming Battle Over Artificial Intelligence Chips https://fortunascorner.com Traders, analysts, and professional portfolio managers will turn their attention to earnings this week, as one-third of S&P 500 companies are set to […]
GW Bio-Phama’s (GWPH’s) Big Day; Cowen & Company’s Top Cannabis-Based Stock Picks
GW Bio-Phama’s (GWPH’s) Big Day; Cowen & Company’s Top Cannabis-Based Stock Picks https://fortunascorner.com It was a great day for GW Bio-Pharma (GWPH), as an FDA Panel today voted 13-0 to approve the company’s cannabinoid-based drug Epidiolex (cannabinoid oral solution),” for the treatment of a severe/rare form of childhood epilepsy/severe seizures citing the positive benefits […]
Shorts Getting Squeezed As GWPH Shares Soar On Positive FDA News
Shares of GWPH are soaring this morning after the company announced that an FDA -staff review of their cannabis-based epilepsy drug — Epidiolex — was positive, writing that “the risk-benefit profile established by the data in the application appears to support approval of the cannabidiol.” Shares are trading up $12.77, or 10.5 percent to $133.45, […]
What People Are Saying